When are biomarkers useful in the management of airway diseases

摘要: Biomarkers are characteristics that objectively measured and evaluated as indicators of biological or pathogenic processes, responses to therapeutic interventions, may provide information on the prognosis progression disease response treatment. They likely be helpful in management airway diseases because heterogeneity their pathobiology. Most biomarkers have been developed assess inflammation (or bronchitis) associated with diseases. These include quantitative cell counts sputum, fraction nitric oxide exhaled breath, various metabolites breath. This review provides a brief description these bio‑ markers particular emphasis how eosinophil neutrophil sputum could used manage such asthma, chronic obstructive pulmonary disease, cough.